Gluten Intolerance Treatment Market Share

European Market Forecast

The Europe gluten intolerance treatment market is slated to register about 34% revenue share by the end of 2035. The increasing review of the broad spectrum of gluten-related disorders, with focused clinical investigations, diagnostic criteria, and therapeutic approaches for different conditions causing gluten intolerance will drive its treatment market in the region.

The prevalence of celiac disease, primarily in Northern European, specifically, in countries like Finland that have a relatively high rate of this condition is gradually leading the region towards improved methods of diagnosis and recognition and treatment of such conditions, bolstering the regional market expansion. Nearly 2.5% of all adults between the ages of 30 and 64 have been diagnosed with celiac disease in Finland.

APAC Market Statistics

The Asia Pacific region is projected to account for 25% of the overall gluten intolerance treatment market share by 2035. The growing concern about gluten intolerance that is on the rise among Asians, especially among the population of China and India is anticipated to boost the market demand in the region.

China and India are the most populous countries in the world and the increasing evolution of modern farming practices for wheat cultivation, with advancements in food processing, has resulted in higher gluten content in wheat which is considered a major factor that will lead to the higher incidence of gluten intolerance in the region.